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Abstract
Background and aims: There a shortage of robust information about profiles of gastrointestinal disease in
sub-Saharan Africa. The endoscopy unit of the University Teaching Hospital in Lusaka has been running
without interruption since 1977 and this 38-year record is largely intact. We report an analysis of endoscopic
findings over this period.
Methods: Written endoscopy records from 29th September 1977 to 16th December 2014 were recovered,
computerised, coded by two experienced endoscopists and analysed. Temporal trends were analysed using
tables, graphs, and unconditional logistic regression, with age, sex of patient, decade, and endoscopist as
independent variables to adjust for inter-observer variation.
Results: Sixteen thousand nine hundred fifty-three records were identified and analysed. Diagnosis of gastric
ulcer rose by 22 %, and that of duodenal ulcer fell by 14 % per decade. Endoscopically diagnosed oesophageal cancer
increased by 32 % per decade, but gastric cancer rose only in patients under 60 years of age (21 % per decade).
Oesophageal varices were the commonest finding in patients presenting with haematemesis, increasing by 14 % per
decade in that patient group. Two HIV-related diagnoses, oesophageal candidiasis and Kaposi’s sarcoma, rose from
almost zero to very high levels in the 1990s but fell substantially after 2005 when anti-retroviral therapy became widely
available.
Conclusions: This useful dataset suggests that there are important trends in some endoscopic findings over
four decades. These trends are not explained by inter-observer variation. Reasons for the divergent trends in
incidence of peptic ulceration and apparent trends in diagnosis of upper gastrointestinal cancers merit further
exploration.
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Background
A longitudinal perspective on disease trends is not only
fascinating, but also essential to understanding aetiology
and pathogenesis. The epidemiology of upper gastro-
intestinal disease in industrialised populations is evolving
rapidly [1–3]. Falling rates of peptic ulceration [4] and
gastric cancer [2] are attributed to declining prevalence
of Helicobacter pylori infection [5, 6]. Oesophageal squa-
mous cell carcinoma remains the most predominant
worldwide, although in developed countries there is a
shift to adenocarcinoma [3, 7–9]. Data from Asia are
similar to those in Western countries with a gradual de-
crease in peptic ulceration and H. pylori infection [10–13].
There is also a reported reduction in peptic ulceration in
Latin America [14].
In Africa, the shortage of data impedes understanding
of the current epidemiology of upper gastrointestinal
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disorders [15] and there is almost no insight into trends
over time. Towards the end of the twentieth century, the
concept of the ‘African enigma’ gained currency, signify-
ing that a high prevalence of H. pylori infection was not
matched by a high burden of attributable upper
gastrointestinal disease [16]. There is abundant evi-
dence that H. pylori infection is common throughout
Africa [17–19]. However, we and others have found
that the burden of upper gastrointestinal disorders is
actually considerably higher than it appeared at first,
and a community survey in Lusaka using endoscopy
found that peptic ulcers were present in 4 % of a poor
urban community, only half of which were symptomatic
[18]. Cancer registry data across Africa are incomplete
[20], but such data as exist indicate that oesophageal car-
cinoma incidence is high [21]. Record linkage methods,
used effectively in industrialised countries, are feasible in
Africa but the lack of computerised medical records
precludes optimal analysis of existing data [22]. As
primary health care in sub-Saharan Africa is patchy,
and frequently inaccessible to all but the urban middle
class, there are few data on the burden of communicable
and non-communicable gastrointestinal disorders. Endos-
copy units, which are an important source of data on
upper gastrointestinal disease [23], are much less well de-
veloped in Africa than in industrialised countries, and not
many of them have records going back for more than a
few years.
The University Teaching Hospital in Lusaka (UTH)
has served the population of this capital city, and in-
deed the whole country and beyond, since the 1970s.
The endoscopy unit in UTH has grown from small
beginnings in 1977 to a unit which now delivers a
daily service and offers diagnostic and therapeutic
upper and lower gastrointestinal endoscopy. One of
the authors (SM) was nurse leader of the unit from
1985 to 2012 and has preserved an almost-complete
set of written records of diagnostic procedures, a
record which began with the founding of the unit in
1977. In the belief that this probably unique archive
may provide insight into emerging trends of disease
in this large African city, we have analysed all the
available records from the unit. The records include
the periods before the emergence of the Human Im-
munodeficiency Virus (HIV) infection and during the
epidemic before and after the availability of antiretro-
viral therapy.
Methods
Endoscopy records
We retrieved all available endoscopy reports since the
inception of the unit from 1977 to 2014. Reports for all
endoscopy procedures from 1977 to 2009 were written
by hand on proformas, and have been kept together.
From 2009, records were entered on computer, but
paper copies of all entries are printed off and kept with
the older written records to avoid loss of data in the
event of computer breakdown. The hand-written records
comprise a wide range of free text entries, in contrast to
which the computerised entries are largely pre-coded.
Written records were missing for the whole year 1986,
and for the period April-December 2008; endoscopies
were performed over these periods, but the records
could not be found. Records were entered into Excel
spread sheets by five people, with verbatim entry of free
text for all clinical fields. No names were entered. Identi-
fication of endoscopist signatures was verified by one of
the nurses (SM) who had been in charge of the unit
from 1985 to 2012. The free text in all written records
was then transferred into Stata 13 (Stata Corp, College
Station, TX) and coded by two experienced endoscopists
(PK and VK). The University of Zambia Biomedical
Research Ethics Committee granted exemption from
ethics review for publication of this retrospective ana-
lysis on 22nd January, 2015; consent was not obtained
for this from patients in view of the 40-year time
span, and this was considered when the waiver was
obtained.
Coding
Free text entries were reviewed and coded into categor-
ies of: (i) endoscopist; (ii) indication for endoscopy;
(iii) findings in the oesophagus; (iv) findings in the
stomach; and (v) findings in the duodenum. All endosco-
pists were coded, but only those who performed more
than 500 procedures are shown and the rest grouped to-
gether as ‘guest doctor’. Upper gastrointestinal haemor-
rhage was coded by searching the “Indications” text
entries for words including “haematemesis”, “bleeding”,
“melaena”, “vomiting blood”, “suspected bleeding varices”,
or “suspected Mallory-Weiss”. Anaemia was coded using
search terms including “anaemia”, “pallor” and all
spelling variants; dysphagia was coded by searching
for “dysphagia”, “difficulty swallowing” and similar terms,
and abdominal pain using terms such as “pain”, “abdo.
pain”, “suspected PUD” and suchlike. All findings in
oesophagus, stomach or duodenum were coded into
categories. Specific search terms for oesophageal can-
didiasis included “candida”, “candidiasis”, “thrush” or
“white plaques”. Varices in oesophagus or stomach were
searched by “varices” with or without any other text. For
oesophageal, gastric or duodenal ulcers, terms included
“ulcer”, “ulceration”, “DU”, “GU”. The term “erosions” was
coded separately as it was frequently associated with
“inflammation” which (depending on site) was coded
with oesophagitis, gastritis or duodenitis. For oesophageal,
gastric or duodenal cancer, the terms included “tumour”,
“growth”, “lesion” and “malignant”, but “polyp”, “nodule”,
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and “smooth growth” were coded as polyp/benign lesion.
Kaposi’s sarcoma (KS), which has a distinctive appearance
was coded separately and the terms such as “KS”,
“Kaposi’s” “Kaposi’s sarcoma” were used. It was not pos-
sible to confirm the diagnoses of cancer or KS by hist-
ology, as these records were not available for most of the
time period under analysis. Children were defined as
16 years of age or less.
Data analysis
Time was analysed in ‘decades’, which although not
perfect 10 year intervals (Table 1) were felt to be use-
ful intervals for analysis. Diagnostic categories were
treated as categorical variables and analysed by fre-
quency, as percentage of records available, and by
logistic regression with sex, age less than 45 or
60 years, endoscopist and decade as independent vari-
ables. Significance testing was carried out using the χ2
test or Fisher’s exact test as appropriate and P < 0.05
considered significant.
Results
A total of 16,953 records were found, entered and veri-
fied, spanning the 38-year period 1977–2014. Among
those 15,773 had the patients’ sex recorded and 8820
(56 %) were men and 6593 (44 %) women (Table 1). Me-
dian age was 37 years (interquartile range 28–50 years)
with no difference between the sexes. There were 16,725
records in which an oesophageal finding was recorded
and interpretable, 16,100 with a gastric finding, and
14,704 with a duodenal finding. The great majority of
procedures were carried out without sedation, which
is a policy decision as resource constraints limit the
number of staff to supervise recovery safely. We are
aware of two deaths in the procedure room over this
period, one unexplained and one in a severely an-
aemic patient being scoped for gastrointestinal (GI)
haemorrhage; there were no deaths in children
though anecdotally we are aware of several instances
when benzodiazepine sedation had to be reversed
with flumazenil.
Endoscopists and inter-observer variation
A total of 37 doctors performed most of the endosco-
pies (31 physicians, 5 surgeons and 1 paediatrician)
and their records could be easily recognised. There
were a few others included simply as ‘guest doctor’.
Thirteen of the 37 doctors contributed over 500 pro-
cedures each, and five contributed over one thousand
each. Many of these span several years, with one con-
tributing over two decades (Fig. 1). With respect to
inter-observer variation there is clear evidence that
doctors differed with respect to diagnosis (Table 2).
There was also variation by medical specialty. Surgical
endoscopists were more likely to diagnose oesophageal
cancer (3.9 % vs 3.2 % by physicians; P = 0.048), and
less likely to diagnose duodenal ulcer (7.1 % vs 9.2 %;
P < 0.0001), oesophageal varices (3.3 % vs 5.4 % respect-
ively; P = 0.0001) or normal findings (34 % vs 66 %;
P = <0.0001). The single paediatrician, who carries
out procedures on both adults and children, was
nevertheless less likely to diagnose cancer (doctor 10 in
Table 1 Patient characteristics and indication for endoscopy, by decade
1977–1985a 1987–1996 1997–2006 2007–2014
n 1674 2627 3388 9264
Male: female 998:569 1606–945 1771–1462 4445:3977 <0.0001
Female % 36 37 45 47
Age (median, IQR) 33, 26–46 35, 27–45 35, 27–47 39, 29–54 0.001
Age groups in years:
Child (under 16) 13 (1) 31 (1) 66 (3) 311 (4)
16–44 888 (72) 1828 (74) 1697 (68) 4646 (57)
45–59 215 (17) 434 (17) 464 (19) 1697 (21)
60 and over 121 (10) 192 (8) 277 (11) 1453 (18) <0.0001
Indication:
Pain 1192 (71) 1957 (75) 1.912 (56) 4566 (49) <0.0001
Dysphagia 64 (4) 99 (4) 222 (8) 961 (11) <0.0001
Haematemesis 193 (12) 194 (8) 276 (22) 1062 (12) <0.0001
Anaemia 30 (2) 63 (3) 14 (1) 187 (2) <0.0001
Percentages are shown in brackets
aNo data from 1986 retrieved, and the last decade is only 8 years so the decades are therefore not uniform
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Table 2). However, the frequent diagnosis of oesophageal
candidiasis by doctors 9 and 11, and lack of such by doc-
tors 1, 2, 3 and 5, actually reflects the period over which
they worked (Fig. 1), as HIV-related disorders were virtu-
ally unknown before about 1984.
Infectious and HIV-related disorders
Two endoscopic diagnoses, oesophageal candidiasis and
Kaposi’s sarcoma (KS), are AIDS-defining diagnoses.
These diagnoses rose steeply during the early years of
the HIV epidemic in Zambia and have declined since
Fig. 1 Contributions of individual endoscopists over the period 1977–2014. Only those endoscopists who contributed over 500 procedures are shown,
except where they were the only doctors performing endoscopy at that time. The other 23 doctors are not shown, for clarity, but contributed 2656
records to the total. The bars at the bottom indicate the equipment in use over the whole period, beginning with non-immersible endoscopes (a)
from 1977 to 1991, then immersible fibre-optic Olympus endoscopes (b) from 1991 to 2003, then fibre-optic Pentax endoscopes with camera
viewing system (c) from 2003 to 2010, and lastly Pentax high-definition video endscopes (d) from 2010 to date
Table 2 Principal endoscopists over time and diagnostic variation
Doctor Period n Children Candida Varices Reflux OCA GU GCA DU KS Normal
1 1977–1980 78 0 0 1 (1) 6 (8) 0 8 (10) 0 12 (16) 0 9 (12)
2 1980–1983 520 9 0 25 (5) 10 (2) 12 (2) 35 (7) 15 (3) 87 (16) 0 63 (13)
3 1980–1985 445 6 6 (1) 14 (3) 2 13 (3) 13 (3) 6 (1) 47 (11) 2 215 (52)
5 1983–1985 347 5 3 (1) 22 (6) 0 15 (4) 44 (13) 5 (1) 15 (4) 0 68 (28)
6 1985–1990 532 7 1 (0.2) 31 (6) 7 (1) 17 (3) 23 (5) 12 (2) 77 (15) 1 183 (38)
7 1988–1998 819 18 51 (6) 22 (3) 86 (11) 10 (1) 29 (4) 8 (1) 62 (8) 3 256 (33)
8 1993–2014 3499 101 202 (6) 220 (7) 63 (2) 115 (3) 210 (6) 110 (3) 398 (12) 24 1502 (50)
9 1995–2010 1199 14 123 (10) 34 (3) 21 (2) 26 (2) 83 (7) 35 (3) 139 (12) 5 353 (31)
10 1997–2014 776 238 48 (6) 46 (6) 29 (4) 12 (2) 29 (4) 8 (1) 62 (8) 1 319 (46)
11 2001–2004 501 8 38 (8) 10 (2) 21 (4) 15 (3) 49 (10) 19 (4) 48 (10) 1 120 (26)
12 2003–2014 1244 33 112 (9) 37 (3) 75 (6) 61 (5) 83 (7) 65 (5) 43 (4) 8 342 (32)
13 2007–2014 2587 50 83 (3) 176 (7) 2 60 (2) 212 (9) 49 (2) 170 (7) 1 1333 (59)
14 2006–2014 730 4 46 (3) 23 (3) 31 (4) 45 (6) 73 (11) 16 (2) 36 (5) 1 246 (41)
15 2011–2014 1107 6 35 (3) 41 (4) 13 (1) 87 (8) 117 (12) 36 (3) 65 (6) 6 519 (56)
16 2011–2012 701 9 54 (8) 17 (3) 0 20 (3) 70 (10) 20 (3) 59 (8) 0 365 (57)
Percentages are shown in brackets, where % ≥1.0. Endoscopies performed by doctors who carried out less than 500 are not shown unless they were the sole
endoscopists over a period of one or more years (see Fig. 1). Findings differed by endoscopist for all disorders (P < 0.0001 for all, except for KS where P = 0.003).
Variation in the length of time contributed reflects the contributions made by some volunteers on short term contracts, some recent trainees who now contribute
to the service regularly, and two deaths among endoscopists in the 1990s. Trainees’ reports are always signed by the supervising doctor and are not reflected in
this table until deemed ready for independent endoscopy
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2005, which is when antiretroviral therapy was scaled up
across Zambia (Fig. 2).
Peptic ulceration
Gastric ulcer (GU) and duodenal ulcer (DU) have been
diagnosed throughout this period, but differ in their
secular trends, with GU rising over time and DU de-
creasing (Fig. 3). Using logistic regression to model the
effects of time on DU in 15,467 records, there has been
a 14 % reduction in DU diagnosis per decade (OR 0.86;
95 % CI 0.82, 0.90; P < 0.0001). Female sex was associ-
ated with a lower risk of DU (OR 0.64; 95 % CI 0.57,
0.71; P < 0.0001). In contrast, in 15,076 records there
has been a steady rise in diagnosis of GU of 22 % per
decade (OR 1.22; 95 % CI 1.15, 1.30; P < 0.0001), and
again women were less likely to have a GU detected
(OR 0.73; 95 % CI 0.64, 0.82; P < 0.0001). When surgical
specialty or individual doctors were included in the regres-
sion models, these changes per decade remained highly
significant, with little effect on odds ratio. In these models
no individual doctor was specifically less or more
likely to diagnose GU, but doctors 5 (a physician) and
12 (a surgeon) were significantly less likely to diag-
nose DU. DU, but not GU, was seasonal (P < 0.0001),
with lower incidence (481, 8 %) in the hot season
(October-December) than during the rainy or cool seasons
(1023, 9.7 %).
Upper gastrointestinal haemorrhage
We identified 1532 patients whose indication for endos-
copy included haematemesis. The commonest endo-
scopic diagnosis was oesophageal varices, followed by
DU and GU (Table 3). Within the group of patients pre-
senting with haematemesis (n = 1517) there were trends
in diagnosis. In logistic regression models, there was a
22 % increase per decade in GU (OR 1.22; 95 % CI
1.05, 1.41; P = 0.007) and a 14 % increase per decade
in oesophageal varices (OR 1.14; 95 % CI 1.02, 1.28;
P = 0.02), but no change in DU incidence (P = 0.42).
Presumptive diagnosis of upper gastrointestinal
malignancy
Oesophageal cancer was presumptively diagnosed in 549
(3.3 %) procedures. This cancer was reported more fre-
quently in recent years, especially so in younger patients
(Table 4). In logistic regression models, we estimate that
there is a 32 % increase in diagnosis of oesophageal can-
cer per decade (OR 1.32; 95 % CI 1.20, 1.45; P < 0.0001),
and this rises to 66 % increase per decade in patients
under 45 years of age (OR 1.66; 95 % CI 1.30, 2.10;
P < 0.0001). The frequency of diagnosis of oesophageal
cancer in patients over 60 remained unchanged. The
logistic regression models suggest that women are less
likely to be diagnosed with cancer (OR 0.56, 95 % CI
Fig. 2 HIV-related disorders over time: oesophageal candidiasis and
Kaposi’s sarcoma are shown. The first publication defining the
emergence of AIDS in Zambia was published in 1984 [24], and
antiretroviral treatment became available at scale through public
health facilities in 2005
Fig. 3 Gastric ulcer (GU) and duodenal ulcer (DU) diagnosis as
percentage of peptic ulcer diagnoses over time
Table 3 Endoscopic findings in 1532 patients with haematemesis
n (%)
Oesophageal varices 366 (24)
Duodenal ulcers 234 (15)
Gastric ulcers 216 (15)
Oesophagitis (reflux or unspecified) 54 (4)
Gastric carcinoma 43 (3)
Oesophageal ulcers 23 (1.5)
Mallory-Weiss tear 9 (0.6)
Oesophageal carcinoma 9 (0.6)
Kaposi’s sarcoma 2 (0.1)
No explanation found 576 (38)
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0.47,0.68; P < 0.0001); this effect was not observed in
patients under 45 years of age (P = 0.29). The tem-
poral trends in oesophageal cancer remained apparent
and even increased after adjusting for doctor such
that the rise in diagnosis by decade increased to 53 %.
In these models, doctors, 7 (surgeon), 9 (physician), 10
(paediatrician) and 13 (physician) made fewer diagnoses of
oesophageal cancer.
Gastric cancer overall did not show this temporal
trend (OR 1.10; 95 % CI 0.98, 1.21; P = 0.056), but in pa-
tients under 60 years of age there was a trend, with in-
creasing detection rates per decade (OR 1.21; 95 % CI
1.03, 1.43; P = 0.02). This trend was not apparent in pa-
tients under 45 years of age. In patients of 60 years of
age or more the frequency of diagnosis of gastric cancer
appears to have declined by 15 % per decade (P = 0.03).
Endoscopic findings in children
The records include 527 children (3.5 % of 14,944 where
the age can be ascertained), where children are defined
as 16 years or below. Only five doctors carried out en-
doscopy on children, one a paediatrician (238 proce-
dures of all and 39/70 (55 %) of those in children under
5 years of age). The majority were normal, but peptic ul-
ceration and oesophageal varices were common also
(Table 5).
Other non-communicable disorders
Reflux oesophagitis was recorded in 399 (2.4 %) proce-
dures, though with some inter-observer variation (see
above). Hiatus hernia was recorded in 110 (0.7 %) and
non-specific oesophagitis (presumably often reflux) in
532 (3.2 %). However, Barrett’s oesophagus was rare,
with only 10 cases recorded. Stricture was found in 540
(3.2 %) patients. Gastric outlet obstruction was found in
314 (1.9 %). Over the last few years we have become
increasingly aware that caustic ingestion (frequently
parasuicide) is a common cause of oesophageal strictures
and gastric outlet obstruction. These findings were
infrequently recognised as due to caustic injury and
often appear as unexplained. In 114 cases where caustic
ingestion was recorded as the indication for endoscopy,
oesophageal stricture was found in 41 (36 %) and gastric
outlet obstruction in 36 (32 %).
Major indications for endoscopy
Abdominal or epigastric pain was the commonest indi-
cation for endoscopy, with 9798 recorded with this indi-
cation. Of 9323 procedures which were complete (ie no
obstruction to the passage of the gastroscope, 4483
(48 %) were normal. If the incomplete procedures are as-
sumed to have been abnormal, then 46 % of all proce-
dures for abdominal pain were normal. Other prominent
findings in patients with abdominal pain were DU (1005,
10 %), GU (664, 6.8 %), and gastric cancer (205, 2.1 %).
Dysphagia was the indication for endoscopy in 1341
(8.6 %) of 15,632 patients whose indication could be
ascertained. Of 1308 whose oesophagus was com-
pletely examined, 354 (27 %) had benign strictures and
360 (27.5 %) had tumours; 346 (26.5 %) were normal;
44 (3.4 %) had oesophageal ulcers, many of whom
would have had giant oesophageal ulcers of HIV
(Fig. 4); and 28 (2.1 %) had achalasia.
Anaemia was the indication for endoscopy in 294
(1.9 %) of 15,632 procedures. Findings in patients re-
ferred for anaemia included GU in 28 (9.7 %), DU in 24
(8.2 %), gastric cancer in 13 (4.4 %), oesophageal varices
in 21 (7.5 %) and oesophageal cancer in 2 (0.7 %). An-
aemia as an indication for endoscopy was associated
with a borderline increased probability of diagnosis of
gastric cancer (OR 1.73, 95 % CI 1.01, 2.96; P = 0.06)
and oesophageal varices (OR 1.59, 95 % CI 1.04, 2.42;
P < 0.05), but not peptic ulceration, which was no
more frequent than in the whole dataset.
Discussion
The substantial time span of this diagnostic record af-
fords an interesting insight into the profile of upper
Table 4 Age distribution of upper GI malignancy
Age group
(years)
1977–1985a 1987–1996 1997–2006 2007–2014 Total
Oesophageal cancer
16–44 4 (13) 13 (31) 12 (21) 82 (27) 111 (25)
45–59 14 (47) 17 (40) 22 (39) 102 (33) 155 (35)
60 and over 12 (40) 12 (29) 22 (39) 125 (40) 171 (39)
Gastric cancer
16–44 4 (19) 12 (29) 38 (37) 46 (22) 100 (27)
45–59 8 (38) 13 (32) 25 (24) 67 (33) 113 (31)
60 and over 9 (43) 16 (39) 39 (38) 92 (45) 156 (42)
aNo data from 1986 retrieved. Decades are not uniform as in Table 1
Table 5 Endoscopic findings in children
Rank
order
Oesophagus,
n = 510
Stomach,
n = 501
Duodenum,
n = 462
1 Normal 400 (78) Normal 417 (83) Normal 385 (83)
2 Varices 49 (10) Gastritis 44 (9) Duodenal ulcers 41 (9)
3 Stricture 16 (3) Gastric ulcers 17 (3) Duodenitis 26 (6)
4 Oesophagitis 7 (3) Gastric outlet
obstruction 9 (2)
Vascular lesion 4 (1)
5 Hiatus hernia 7 (1) Growths/polyps 5 (1) Villous atrophy 3 (1)
6 Ulcers 4 (1) Gastric erosions 4 (1) Polyp 2 (0.5)
7 Other 1 (0.2) Vascular lesions 2 (0.5) Stricture 1 (0.2)
Endoscopic findings in children in descending order of frequency n (%).
Percentages are shown in brackets
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gastrointestinal disease in Zambia over the last 4 de-
cades, with evidence of important trends. Retrospective
analysis of data like these is inevitably fraught with diffi-
culties of interpretation, notably the inevitable turnover
of staff which when combined with inter-observer vari-
ation generates changes in diagnostic patterns. However,
the length of service of a few doctors who contributed
the most to the record provides some consistency in
diagnostic language, which may ameliorate some of
these uncertainties. Furthermore, doctor 8 (Fig. 1) also
taught endoscopy to doctors 9, 11, 12, 13, 14 and 15,
which reinforces a consistency in the diagnostic nos-
ology and helps to reduce inter-observer variation. There
are differential trends for peptic ulceration (GU increas-
ing and DU decreasing, and increasing diagnosis of
oesophageal but not gastric cancer) so these changes are
not merely a consequence of greater use of the endos-
copy unit.
The burden imposed by HIV on the population of
Zambia over the period of this analysis has been heavy,
and this is reflected in the dramatic changes in
oesophageal candidiasis and Kaposi’s sarcoma. The first
description of the new ‘epidemic’ form of KS in this
same hospital was published in 1984 [24] and it is clear
from Fig. 2 that gastrointestinal KS and oesophageal
candidiasis were both rare before then, even though HIV
must have been circulating. The steep rise in these diag-
noses in the 1980s and 1990s reflects the rising HIV
seroprevalence over those years. It is satisfying to note
the substantial fall in both diagnoses since the wide-
spread use of ART. These findings are consistent with
findings in Zimbabwe and Uganda where a reduction in
KS cases (not gastrointestinal) has been reported during
the ART era [25, 26]. We have also shown that
oesophageal candidiasis, once the most common finding
in patients with HIV infection, has been declining with
more widespread use of ART. This was observed in the
USA also [27]. In addition to reduced incidence of can-
didiasis we have also seen a reduction in severity which
is hard to measure; in the 1990s candidiasis was some-
times so severe as to block the air/water channel of the
endoscope, but this is very rare now. Cases are still seen,
however, and anecdotally we find that most of these
occur in patients who have not had a diagnosis of HIV.
The burden of cancer is increasing in Sub-Saharan
Africa with the burden expected to double within the
next 20 years [28] leading to an estimated 1 million can-
cer deaths per year by 2030 [29]. The temporal trends in
endoscopic diagnosis of upper GI malignancy we report
here are of particular concern. Both oesophageal cancer
and gastric cancer appear to have risen in adults under
60 years of age. In contrast, in patients of 60 years of age
or more the frequency of diagnosis of gastric cancer
appears to have declined by 15 % per decade, and the
frequency of diagnosis of oesophageal cancer in pa-
tients over 60 has remained unchanged. These differ-
ential trends suggest that the changes are not merely
due to improved endoscopic equipment or changes in
personnel, but we cannot rule out the possibility that
these temporal trends may be influenced by changes
in awareness and referral pattern. As this was a retro-
spective review, we could not confirm the histological
diagnosis in these cancer cases. However, GI cancers
in Africa often present with advanced, unmistakeable
lesions, and the high proportion of cancer in young
adults is consistent with our findings in recent studies in
which the diagnosis was confirmed histologically [30–32].
In the UK, less than 5 % of upper GI cancers are under
50 years of age [33], but a report from Tanzania 29 % of
gastric cancer cases were under 50 years of age [34], and
this is true of oesophageal cancer in Ghana [35] and
Kenya [36]. Our findings may therefore be representative
of Africa more widely.
An important contributor to the temporal trends is re-
ferral pattern. When the endoscopy service first began,
in 1977, health care in Zambia was free at the point of
care and was fully supported by the government. After
1991 when most of the state’s assets were being priva-
tised and the economy could no longer support free
health care for all, cost sharing user fees were introduced
in government hospitals including UTH. A state insur-
ance scheme was later introduced but suffered from the
drawback that, as it was not compulsory, contributions
were often only made when the potential contributor
was feeling ill and wanted care, so it was in effect a form
of user fee. Currently, medical care remains free for chil-
dren and elderly patients and for those with communic-
able diseases such as HIV infection or Tuberculosis.
Diagnostic services attract fees, and the fee for endoscopy
Fig. 4 Giant oesophageal ulcers of HIV
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is now ZMW 150 (USD 22 approximately), which repre-
sents a considerable barrier to investigation as 60.5 % of
the population in Zambia are living in poverty and can
barely afford it. User fees have thus been applied to endos-
copy for almost all of the last 24 years. While these
changes have been going on, referral patterns have almost
certainly changed, but in a way that is difficult to quantify.
Awareness of the endoscopy service around the country
has certainly changed over the last four decades, and this
may help explain the rising diagnostic rate of oesophageal
varices. Our analysis may suffer from a selection bias as
only those who could afford user fees and transport costs
would have been able to attend the endoscopy unit. The
cohort selection could also have been affected by referral
awareness by the referring doctors and easy of geograph-
ical accessibility to the service. In order to reduce these
biases, we have in our analyses considered proportions of
diagnoses made as opposed to absolute numbers.
The proportion of patients who were referred for ab-
dominal pain who had a normal endoscopy was high at
48 %. This figure is consistent with reports from other
countries and is consistent with our clinical impression
that functional dyspepsia is just as common in Africa as
elsewhere. Oesophageal varices were found to be the
most common cause of haematemesis, and most of these
are attributed to Schistosoma mansoni infection [30, 37].
Other African investigators within the region have also
reported oesophageal varices as the leading cause of
haematemesis, in contrast to the dominance of peptic
ulceration in industrialised countries [30, 38, 39], but
this may vary across the continent. Duodenal ulcer (DU)
is assumed to be due to H. pylori infection, which is
common [18], but this is not routinely confirmed as
confirmation is costly and probably unnecessary in
the light of the high seroprevalence. The seasonality
of DU, with lower incidence in the hot season, is
consistent with data from other countries [40] but re-
mains unexplained.
These data from one endoscopy unit provide a useful
insight into profiles of upper gastrointestinal disease in
Zambia, and they differ substantially from current trends
in industrialised countries. There is a serious shortage of
data on the epidemiology of gastrointestinal disease in
Africa [41], but we can predict that further changes will
occur, and these may be rapid in the increasing number
of people surviving long term with HIV infection [42].
These endoscopy records go some way to identifying
issues which require urgent investigation, prominent
among which is the disturbing incidence of oesophageal
and gastric cancer in young adults.
Conclusions
These data from an African endoscopy unit suggest that
the profile of upper gastrointestinal disease is evolving
over time. The profile of diagnosis has some import-
ant local characteristics, such as the dominance of
oesophageal varices as a cause of haemorrhage which
other evidence suggests is largely due to schistosomiasis.
There are also common features which would be found in
any endoscopy unit anywhere in the world. The emerging
problem of cancer in younger adults, and the apparent
changes in peptic ulceration, merit further study.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
VK and PK originated the idea, set up the data collection, coded the findings,
analysed the data and wrote the first draft of the manuscript. SM curated the
records over a 28 year period and together with RS and TB participated in
sorting records, data extraction and identification of endoscopists and
contributors. CM, EP and PM carried out data extraction and entry. BK
contributed a section on user fees which may contribute to selection
bias, and together with ES, BA, IZ and JBN discussed the interpretation
of the findings. All authors then went through and edited the manuscript
through several revisions and approve the final manuscript.
Authors’ information
Not applicable.
Acknowledgements
We are grateful to Ruth Mubiana and Vutita Dokowe for data entry. The
following doctors are acknowledged for their contributions to the work of
the endoscopy unit over this time: Dr Asombang, Dr Dean, Dr Johnson,
Dr Kayembe, Dr Leaver, Dr Louis-Auguste, Dr Mark, Professor Mulla, Dr Mundia,
Dr Munkonge, Dr Namushi, Professor Odimba, Dr Raymond, Dr Squarr,
Dr Watters and Dr Zimba. We apologise to any other staff whose contributions
we have accidentally omitted, and would be most grateful to hear from them.
VK was supported by the NIH Research Training Grant # R25 TW009337 funded
by the Fogarty International Center, Office of the Director, National Institutes of
Health, the National Heart, Blood, and Lung Institute, and the National Institute
of Mental Health.
Author details
1TROPGAN, Department of Medicine, University of Zambia School of
Medicine, University Teaching Hospital, Nationalist Road, Lusaka, Zambia.
2Copperbelt University School of Medicine, Ndola, Zambia. 3Department of
Surgery, University Teaching Hospital, Lusaka, Zambia. 4Blizard Institute, Barts
& The London School of Medicine, Queen Mary University of London, 4
Newark Street, London E1 2AD, UK.
Received: 10 July 2015 Accepted: 22 September 2015
References
1. Sonnenberg A. Historic changes of Helicobacter pylori-associated diseases.
Aliment Pharmacol Ther. 2013;38:329–42.
2. Goldacre MJ. Demography of aging and the epidemiology of gastrointestinal
disorders in the elderly. Best Pract Res Clin Gastroenterol. 2009;23:793–804.
3. Rustgi AK, El-Serag HB. Esophageal cancer. NEJM. 2014;371:2499–509.
4. Loffeld RJ, Liberov B, Dekkers PE. The changing prevalence of upper
gastrointestinal endoscopic diagnoses: a single-centre study. Neth J Med.
2012;70:222–6.
5. National Cancer Intelligence Network. Incidence of stomach cancer in
England, 1998–2007. http://www.ncin.org.uk/publications/data_briefings/
incidence_of_stomach_cancer_in_England, accessed on 13th February 2015.
6. Vyse AJ, Gay NJ, Hesketh LM, Andrews NJ, Marshall B, Thomas HI, et al. The
burden of Helicobacter pylori infection in England and Wales. Epidemiol
Infect 2002;128:411-7.
7. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma.
Lancet. 2013;381:400–12.
Kayamba et al. BMC Gastroenterology  (2015) 15:127 Page 8 of 9
8. Devesa SS, Blot WJ, Fraumeni Jr JF. Changing patterns in the incidence
of esophageal and gastric carcinoma in the United States. Cancer.
1998;83:2049–53.
9. Kocher HM, Linklater K, Patel S, Ellul JP. Epidemiological study of
oesophageal and gastric cancer in south-east England. Br J Surg.
2001;88:1249–57.
10. Xia B, Xia HH, Ma CW, Wong KW, Fung FM, Hui CK, et al. Trends in the
prevalence of peptic ulcer disease and Helicobacter pylori infection in
family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Aliment Pharmacol Ther 2005; 22: 243-9.
11. Wong SN, Sollano JD, Chan MM, Carpio RE, Tady CS, Ismael AE, et al.
Changing trends in peptic ulcer prevalence in a tertiary care setting in the
Philippines: a seven-year study. J Gastroenterol Hepatol. 2005;20:628-32.
12. Nakajima S, Nishiyama Y, Yamaoka M, Yasuoka T, Cho E. Changes in the
prevalence of Helicobacter pylori infection and gastrointestinal diseases in
the past 17 years. J Gastroenterol Hepatol. 2010;25 Suppl 1:S99–110.
13. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific
region. J Dig Dis. 2007;8:179–85.
14. Saul C, Teixeira CR, Pereira-Lima JC, Torresini RJ. Prevalence reduction of
duodenal ulcer: a Brazilian study (retrospective analysis in the last decade:
1996–2005). Arq Gastroenterol. 2007;44:320–4.
15. Somdyala NI, Parkin DM, Sithole N, Bradshaw D. Trends in cancer incidence
in rural Eastern Cape Province; South Africa, 1998–2012. Int J Cancer.
2015;136:E470–4.
16. Holcombe C. Helicobacter pylori: the African enigma. Gut. 1992;33:429–31.
17. Tanih NF, Dube C, Green E, Mkwetshana N, Clarke AM, Ndip LM, et al. An
African perspective on Helicobacter pylori: prevalence of human infection,
drug resistance, and alternative approaches to treatment. Ann Trop Med
Parasitol. 2009;103:189–204.
18. Fernando N, Holton J, Zulu I, Vaira D, Mwaba P, Kelly P. Helicobacter pylori
infection in an urban African population. J Clin Microbiol. 2001;39:1323–7.
19. http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/
11_helicobacter_pylori_developing_countries_en.pdf, Accessed on 21/01/15.
20. Parkin DM, Bray F, Ferlay J, Jemal A. Cancer in Africa 2012. Cancer Epidemiol
Biomarkers Prev. 2014;23:953–66.
21. Ferlay J, Soerjomataram I, Ervik M, Forman D, Bray F, Dikshit R, et al.
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC
CancerBase No. 11 [Internet]. Lyon, France: International Agency for
Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed
18/10/2014.
22. Mbulaiteye SM, Bhatia K, Adebamowo C, Sasco AJ. HIV and cancer in Africa:
mutual collaboration between HIV and cancer programs may provide
timely research and public health data. Infect Agent Cancer. 2011;6:16.
23. Dominguez RL, Crockett SD, Lund JL, Suazo LP, Heidt P, Martin C, et al.
Gastric cancer incidence estimation in a resource-limited nation: use of
endoscopy registry methodology. Cancer Causes Control 2013;24:233-9.
24. Bayley AC. Aggressive Kaposi’s sarcoma in Zambia, 1983. Lancet.
1984;1(8390):1318–20.
25. Chokunonga E, Borok MZ, Chirenje ZM, Nyakabau AM, Parkin DM. Trends in
the incidence of cancer in the black population of Harare, Zimbabwe
1991–2010. Int J Cancer. 2013;133:721–9.
26. Wabinga HR, Nambooze S, Amulen PM, Okello C, Mbus L, Parkin DM. Trends
in the incidence of cancer in Kampala, Uganda 1991–2010. Int J Cancer.
2014;135:432–9.
27. Monkemuller KE, Call SA, Lazenby AJ, Wilcox CM. Declining prevalence of
opportunistic gastrointestinal disease in the era of combination antiretroviral
therapy. Am J Gastroenterol. 2000;95:457–62.
28. Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M, et al. Cancer
burden in Africa and opportunities for prevention. Cancer 2012;118:4372-84.
29. Sylla BS, Wild CP. A million Africans a year dying from cancer by 2030: what
can cancer research and control offer to the continent? Int J Cancer.
2012;130:245–50.
30. Kelly P, Katema M, Amadi B, Zimba L, Aparicio S, Mudenda V, et al.
Gastrointestinal pathology in the University Teaching Hospital, Lusaka,
Zambia - review of endoscopic and pathology records. Trans Roy Soc Trop
Med Hyg 2008;102:194-199.
31. Kayamba V, Asombang AW, Mudenda V, Lisulo MM, Sinkala E,
Mwanamakondo S, et al. Gastric adenocarcinoma in Zambia:
a case–control study of HIV, lifestyle risk factors, and biomarkers of
pathogenesis. S Afr Med J. 2013;103:255–9.
32. Kayamba V, Bateman AC, Asombang A, Shibemba A, Zyambo K, Banda T,
et al. HIV infection and domestic smoke exposure, but not human papillomavirus,
are risk factors for oesophageal squamous cell carcinoma in Zambia: a case-
control study, Cancer Medicine, 2014 in press. doi: 10.1002/cam4.434.
33. Coupland VH, Allum W, Blazeby JM, Mendall MA, Hardwick RH, Linklater KM,
et al. Incidence and survival of oesophageal and gastric cancer in England
between 1998 and 2007, a population-based study. BMC Cancer 2012;12:11.
34. Mabula JB, McHembe MD, Koy M, Chalya PL, Massaga F, Rambau PF, et al.
Gastric cancer at a university teaching hospital in northwestern Tanzania: a
retrospective review of 232 cases. World J Surg Oncol 2012;10:257.
35. Tettey M, Edwin F, Aniteye E, Sereboe L, Tamatey M, Ofosu-Appiah E, et al.
The changing epidemiology of esophageal cancer in sub-Saharan Africa -
the case of Ghana. Pan Afr Med J. 2012;13:6.
36. Parker RK, Dawsey SM, Abnet CC, White RE. Frequent occurrence of
esophageal cancer in young people in western Kenya. Dis Esophagus.
2010;23:128–35.
37. Sinkala E, Kapulu M, Besa E, Zyambo K, Chisoso NJ, Foster GR, et al.
Hepatosplenic schistosomiasis is characterised by high blood markers of
translocation, inflammation and fibrosis. Liver Int. In press.
38. Alema ON, Martin DO, Okello TR. Endoscopic findings in upper
gastrointestinal bleeding patients at Lacor hospital, northern Uganda.
Afr Health Sci. 2012;12:518–21.
39. Jaka H, Koy M, Liwa A, Kabangila R, Mirambo M, Scheppach W, et al. A
fibreoptic endoscopic study of upper gastrointestinal bleeding at 10.1186/
s12876-015-0353-8 Bugando Medical Centre in northwestern Tanzania: a
retrospective review of 240 cases. BMC Res Notes 2012;5:200.
40. Fares A. Global patterns of seasonal variation in gastrointestinal diseases.
J Postgrad Med. 2013;59:203–7.
41. Asombang AW, Kelly P. Gastric cancer in Africa: what do we know about
incidence and risk factors? Trans R Soc Trop Med Hyg. 2012;106:69–74.
42. Kelly P, Saloojee H, Chen J, Chung RT. Non-communicable disease in HIV
infected adults in Africa: gastrointestinal, hepatic and nutritional disorders.
JAIDS. 2014;67 Suppl 1:S79–86.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kayamba et al. BMC Gastroenterology  (2015) 15:127 Page 9 of 9
